Generics BulletinHBW InsightIn VivoMedtech InsightPink SheetScrip

Generics Bulletin

Medtech Insight

Shire Buys FerroKin BioSciences To Further Hematology Strategy

Mar 15 2012

• By Jessica Merrill

Related Content

Deals of the Week: Stada/Grunenthal, Stada/Spirig, Shire/Sangamo

Feb 06 2012

Shire Withdraws <em>Replagal</em> BLA Rather Than Conduct Lengthy Trials – <em>Updated</em>

Mar 15 2012

Related Companies

Takeda Pharmaceutical Co. Ltd.

GSK plc

Novartis AG

Sangamo Therapeutics, Inc.

Additional Topics

Deals BioPharmaceutical

More from Archive

More from Pink Sheet

Twitter feed RSS feed RSS feed

About UsOpens in new window
Meet the TeamOpens in new window
RSS FeedOpens in new window

Contact Us
Customer Service
Subscribe
AdvertisingOpens in new window
Feedback

Terms and ConditionsOpens in new window

Privacy PolicyOpens in new window